CN110279803A - A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification - Google Patents

A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification Download PDF

Info

Publication number
CN110279803A
CN110279803A CN201910625927.7A CN201910625927A CN110279803A CN 110279803 A CN110279803 A CN 110279803A CN 201910625927 A CN201910625927 A CN 201910625927A CN 110279803 A CN110279803 A CN 110279803A
Authority
CN
China
Prior art keywords
parts
drug
heat
pathogenic factors
eliminate pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910625927.7A
Other languages
Chinese (zh)
Inventor
许嘉鹏
杨昕燕
何春荣
杨宁
杨勤运
何亚迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Traditional Chinese Medicine Hospital Of Chuxiong Yi Autonomous Prefecture
Original Assignee
Traditional Chinese Medicine Hospital Of Chuxiong Yi Autonomous Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Traditional Chinese Medicine Hospital Of Chuxiong Yi Autonomous Prefecture filed Critical Traditional Chinese Medicine Hospital Of Chuxiong Yi Autonomous Prefecture
Priority to CN201910625927.7A priority Critical patent/CN110279803A/en
Publication of CN110279803A publication Critical patent/CN110279803A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

To solve the deficiencies in the prior art, it the present invention provides the drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, is calculated with mass fraction, comprising: 12-39 parts of main ingredient part, 6.5-23 parts of dispensing portion.The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion includes: rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.The drug of institute of the invention has strengthening vital QI to eliminate pathogenic factors, and heat-clearing detoxification effect for fever caused by lung deficiency of spleen and stomach, cough, pharyngalgia, out of strength, indigestion and loss of appetite, vomiting, frequent micturition, urinates the illnesss such as red with significant curative effect.Furthermore, the present invention drug raising, reparation, adjustment effect can be played to the immune function of HIV incubation period, period of disease, initial stages of restoration body, the life quality of patient is improved, the process of disease is delayed, to can reach the effect for extending patient vitals, and toxicity is not found.

Description

A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification
Technical field
The invention belongs to field of medicine preparing technology, and in particular to the drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification.
Background technique
Strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification are a kind for the treatment of methods of common treating both manifestation and root cause of disease of traditional Chinese medicine, are used for physically weak and malicious heresy Invasion or the evil invasion body of poison cause physically weak in turn.This method kills the virus for suppression, improves body due to malicious evil invasion or and leads The a series of symptoms clinical effectiveness of cause is than more significant, and toxic side effect is smaller.Existing similar kind has Fuzheng Kang toxic capsule: helping The recipe composition of just antitoxin capsule is the drugs such as ginseng, Rhizoma Atractylodis Macrocephalae, Radix Astragali, rhizoma polygonati, the fruit of glossy privet, Radix Glycyrrhizae, has supplementing qi and nourishing yin, nourshing kidney Invigorating the spleen, heat-clearing toxin-expelling functions.But the drug is mainly used for the incubation period of treated disease, and this medicine can be used for disease Period of disease and remaining heresy unclear convalescence.
Summary of the invention
The present invention is in view of the deficienciess of the prior art, provide the drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, with quality Number calculates, comprising: 12-39 parts of main ingredient part, 6.5-23 parts of dispensing portion.The main ingredient part include: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion includes: rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
Further, it is calculated with mass fraction, the main ingredient part includes: 4-10 parts of American Ginseng, 1-5 parts of Radix Astragali, Rhizoma Atractylodis Macrocephalae 2-6 parts, 2-8 parts of chicken root, 1-5 parts of aleppo avens herb, 2-5 parts of rhizoma polygonati.
Further, it is calculated with mass fraction, the dispensing portion includes: 2-6 parts of rubia yunnanensis, 1-6 parts of CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae 2-4 parts, 0.5-3 parts of Honeysuckle flower, 1-4 parts of Radix Glycyrrhizae.
Further, it is calculated with mass fraction, comprising: 20-26 parts of main ingredient part and 10-15 parts of dispensing portion.
Further, the drug of the strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification is ebonite medicine capsule.
Further, the preparation method of the ebonite medicine capsule includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 0.5-3 hours, decocts 1-4 It is secondary, it is 1-3 hours each.
S2. merge step S1 and decoct gained medical fluid every time, be concentrated into after filtering (45~50 DEG C) relative density for 1.25~ 1.35 clear cream.
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the hard capsule medicine after encapsulated Object.
Further, it soaks in water, is calculated with solid-liquid mass ratio, solid phase described in step S1: liquid phase=1:5-15.
Further, it is soaked in water before decocting for the first time, at decoction operation progress 2 times and 2 times or more with solid described in step S1 Liquid mass ratio calculates, solid phase: liquid phase=1:13-15.Amount of water before last time decocts, is calculated, solid phase: liquid with solid-liquid mass ratio Phase=1:5-7.Amount of water before the decoction of intermediate number, solid-liquid mass ratio are successively successively decreased by number is equal.
One of the present invention has at least the following advantages:
1. the drug of institute of the invention is with strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification effect, for fever caused by lung deficiency of spleen and stomach, cough It coughs, pharyngalgia, out of strength, indigestion and loss of appetite, vomiting, frequent micturition, urinate the illnesss such as red with significant curative effect.
2. the present invention drug HIV incubation period, period of disease, the immune function of initial stages of restoration body can be played and mentioned High, reparation, adjustment effect, have improved the life quality of patient, have delayed the process of disease, suffer to can reach extension The effect of person's life, and toxicity is not found.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, below to of the invention further detailed Explanation.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not intended to limit the present invention.
Embodiment 1
The drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, is calculated, comprising: 25 parts of main ingredient part, and portion of making up a prescription with mass fraction Divide 12 parts.The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion packet It includes: rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
It is calculated with mass fraction, the main ingredient part includes: 7 parts of American Ginseng, 2 parts of Radix Astragali, 4 parts of Rhizoma Atractylodis Macrocephalae, 6 parts of chicken root, five 3 parts, 3 parts of rhizoma polygonati of grass of gas southern exposure.
It is calculated with mass fraction, the dispensing portion includes: 4 parts of rubia yunnanensis, 2 parts of CAULIS MARSDENIAE TENACISSIMAE, 3 parts of radix scutellariae, Honeysuckle flower 1 Part, 2 parts of Radix Glycyrrhizae.
Embodiment 2
The drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, is calculated, comprising: 39 parts of main ingredient part, dispensing portion with mass fraction 23 parts.The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion includes: Rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
It is calculated with mass fraction, the main ingredient part includes: 10 parts of American Ginseng, 5 parts of Radix Astragali, 6 parts of Rhizoma Atractylodis Macrocephalae, 8 parts of chicken root, five 5 parts, 5 parts of rhizoma polygonati of grass of gas southern exposure.
It is calculated with mass fraction, the dispensing portion includes: 6 parts of rubia yunnanensis, 6 parts of CAULIS MARSDENIAE TENACISSIMAE, 4 parts of radix scutellariae, Honeysuckle flower 3 Part, 4 parts of Radix Glycyrrhizae.
Embodiment 3
The drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, is calculated, comprising: 12 parts of main ingredient part, dispensing portion with mass fraction 6.5 part.The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion packet It includes: rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
It is calculated with mass fraction, the main ingredient part includes: 4 parts of American Ginseng, 1 part of Radix Astragali, 2 parts of Rhizoma Atractylodis Macrocephalae, 2 parts of chicken root, five 1 part, 2 parts of rhizoma polygonati of grass of gas southern exposure.
It is calculated with mass fraction, the dispensing portion includes: 2 parts of rubia yunnanensis, 1 part of CAULIS MARSDENIAE TENACISSIMAE, 2 parts of radix scutellariae, Honeysuckle flower 0.5 Part, 1 part of Radix Glycyrrhizae.
Embodiment 4
The drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, is calculated, comprising: 26 parts of main ingredient part, and portion of making up a prescription with mass fraction Divide 15 parts.The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion packet It includes: rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
It is calculated with mass fraction, the main ingredient part includes: 7 parts of American Ginseng, 3 parts of Radix Astragali, 4 parts of Rhizoma Atractylodis Macrocephalae, 6 parts of chicken root, five 3 parts, 3 parts of rhizoma polygonati of grass of gas southern exposure.
It is calculated with mass fraction, the dispensing portion includes: 4 parts of rubia yunnanensis, 3 parts of CAULIS MARSDENIAE TENACISSIMAE, 3 parts of radix scutellariae, Honeysuckle flower 2 Part, 3 parts of Radix Glycyrrhizae.
Embodiment 5
The drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, is calculated, comprising: 20 parts of main ingredient part, dispensing portion with mass fraction 10 parts.The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion includes: Rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
It is calculated with mass fraction, the main ingredient part includes: 5 parts of American Ginseng, 2 parts of Radix Astragali, 3 parts of Rhizoma Atractylodis Macrocephalae, 3 parts of chicken root, five 3 parts, 4 parts of rhizoma polygonati of grass of gas southern exposure.
It is calculated with mass fraction, the dispensing portion includes: 2.5 parts of rubia yunnanensis, 2 parts of CAULIS MARSDENIAE TENACISSIMAE, 3 parts of radix scutellariae, Honeysuckle flower 1 Part, 1.5 parts of Radix Glycyrrhizae.
Embodiment 6
The drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, is calculated, comprising: 24 parts of main ingredient part, dispensing portion with mass fraction 13 parts.The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati.The dispensing portion includes: Rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
It is calculated with mass fraction, the main ingredient part includes: 6 parts of American Ginseng, 4 parts of Radix Astragali, 4 parts of Rhizoma Atractylodis Macrocephalae, 4 parts of chicken root, five 3 parts, 3 parts of rhizoma polygonati of grass of gas southern exposure.
It is calculated with mass fraction, the dispensing portion includes: 3 parts of rubia yunnanensis, 3 parts of CAULIS MARSDENIAE TENACISSIMAE, 3 parts of radix scutellariae, Honeysuckle flower 2 Part, 2 parts of Radix Glycyrrhizae.
Applicant has found after study, and the drug of present invention institute is with strengthening vital QI to eliminate pathogenic factors, the effect of heat-clearing detoxification, for lung spleen Fever caused by deficiency of the kidney void, pharyngalgia, out of strength, indigestion and loss of appetite, vomiting, frequent micturition, urinates the illnesss such as red with significant curative effect at cough.Meanwhile This product is that the Chuxiong Prefecture hospital of traditional Chinese hospital is compiling proved recipe of the Yi nationality, distributed over Yunnan, Sichuan and Guizhou folk therapy HIV/AIDS patient with similar symptom for a long time On the basis of Yi nationality's medicine compound preparation for the treatment of AIDS for summing up, we have found by long-term observation on Clinical Application: this product pair HIV incubation period, period of disease, the immune function of initial stages of restoration body can play raising, reparation, adjustment effect, improve The life quality of patient, has delayed the process of disease, to can reach the effect for extending patient vitals, and does not find malicious secondary anti- It answers.
Embodiment 7
Drug based on strengthening vital QI to eliminate pathogenic factors described in embodiment 1-6 any embodiment, heat-clearing detoxification, the strengthening vital QI to eliminate pathogenic factors, heat-clearing The drug of detoxification is ebonite medicine capsule.
The preparation method of the ebonite medicine capsule includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 2 hours, decocts 2 times, every time 2 Hour.It soaks in water described in step S1, is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:10.
S2. merge step S1 and decoct gained medical fluid every time, it is 1.30 that (45~50 DEG C) to relative density is concentrated after filtering Clear cream.
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the hard capsule medicine after encapsulated Object.
Embodiment 8
Drug based on strengthening vital QI to eliminate pathogenic factors described in embodiment 1-6 any embodiment, heat-clearing detoxification, the strengthening vital QI to eliminate pathogenic factors, heat-clearing The drug of detoxification is ebonite medicine capsule.
The preparation method of the ebonite medicine capsule includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 3 hours, decocts 4 times, every time 3 Hour.It soaks in water described in step S1, is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:15.
S2. merge step S1 and decoct gained medical fluid every time, it is 1.35 that (45~50 DEG C) to relative density is concentrated after filtering Clear cream.
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the hard capsule medicine after encapsulated Object.
Embodiment 9
Based on strengthening vital QI to eliminate pathogenic factors described in embodiment 1-6 any embodiment, the drug of heat-clearing detoxification, the strengthening vital QI to eliminate pathogenic factors, heat-clearing The drug of detoxification is ebonite medicine capsule.
The preparation method of the ebonite medicine capsule includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 0.5 hour, decoction 1 time, often Secondary 1 hour.It soaks in water described in step S1, is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:5.
S2. merge step S1 and decoct gained medical fluid every time, it is 1.25 that (45~50 DEG C) to relative density is concentrated after filtering Clear cream.
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the hard capsule medicine after encapsulated Object.
Embodiment 10
Drug based on strengthening vital QI to eliminate pathogenic factors described in embodiment 1-6 any embodiment, heat-clearing detoxification, the strengthening vital QI to eliminate pathogenic factors, heat-clearing The drug of detoxification is ebonite medicine capsule.
The preparation method of the ebonite medicine capsule includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 2 hours, decocts 2 times, every time 2 Hour.It soaks in water, is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:14 before decocting for the first time.Amount of water before second of decoction, It is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:5.
S2. merge step S1 and decoct gained medical fluid every time, it is 1.30 that (45~50 DEG C) to relative density is concentrated after filtering Clear cream.
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the hard capsule medicine after encapsulated Object.
Embodiment 11
Drug based on strengthening vital QI to eliminate pathogenic factors described in embodiment 1-6 any embodiment, heat-clearing detoxification, the strengthening vital QI to eliminate pathogenic factors, heat-clearing The drug of detoxification is ebonite medicine capsule.
The preparation method of the ebonite medicine capsule includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 2 hours, decocts 3 times, every time 2 Hour.It soaks in water, is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:13 before decocting for the first time.Amount of water before second of decoction, It is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:10.Amount of water before last time decocts, is calculated, solid phase with solid-liquid mass ratio: Liquid phase=1:7.
S2. merge step S1 and decoct gained medical fluid every time, it is 1.30 that (45~50 DEG C) to relative density is concentrated after filtering Clear cream.
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the hard capsule medicine after encapsulated Object.
Embodiment 12
Drug based on strengthening vital QI to eliminate pathogenic factors described in embodiment 1-6 any embodiment, heat-clearing detoxification, the strengthening vital QI to eliminate pathogenic factors, heat-clearing The drug of detoxification is ebonite medicine capsule.
The preparation method of the ebonite medicine capsule includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 2 hours, decocts 4 times, every time 2 Hour.It soaks in water, is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:15 before decocting for the first time.Amount of water before second of decoction, It is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:12.Amount of water before third time decocts, is calculated, solid phase: liquid with solid-liquid mass ratio Phase=1:9.Amount of water before last time decocts, is calculated, solid phase: liquid phase=1:6 with solid-liquid mass ratio.By grinding for applicant Study carefully, when this step carries out repeatedly decocting operation, by control first and last time solid-to-liquid ratio, and solid-liquid when controlling intermediate decoct that successively decreases Than on the one hand reducing total liquid measure when next step concentration operation, reducing concentration time.On the other hand final production can be significantly improved The drug effect 10-30% of product.
S2. merge step S1 and decoct gained medical fluid every time, it is 1.30 that (45~50 DEG C) to relative density is concentrated after filtering Clear cream.
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the hard capsule medicine after encapsulated Object.
One of the present invention has at least the following advantages:
1. the drug of institute of the invention is with strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification effect, for fever caused by lung deficiency of spleen and stomach, cough It coughs, pharyngalgia, out of strength, indigestion and loss of appetite, vomiting, frequent micturition, urinate the illnesss such as red with significant curative effect.
2. the present invention drug HIV incubation period, period of disease, the immune function of initial stages of restoration body can be played and mentioned High, reparation, adjustment effect, have improved the life quality of patient, have delayed the process of disease, suffer to can reach extension The effect of person's life, and toxicity is not found.
It should be noted that and understand, in the case where not departing from spirit and scope required by the claims in the present invention, energy It is enough that various modifications and improvements are made to the present invention of foregoing detailed description.It is therefore desirable to protection technical solution range not by The limitation of given any specific exemplary teachings.

Claims (8)

1. the drug of a kind of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification, which is characterized in that calculated with mass fraction, comprising: main ingredient part 12- 39 parts, 6.5-23 parts of dispensing portion；The main ingredient part includes: American Ginseng, Radix Astragali, Rhizoma Atractylodis Macrocephalae, chicken root, aleppo avens herb, rhizoma polygonati； The dispensing portion includes: rubia yunnanensis, CAULIS MARSDENIAE TENACISSIMAE, radix scutellariae, Honeysuckle flower, Radix Glycyrrhizae.
2. the drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification according to claim 1, which is characterized in that it is calculated with mass fraction, it is described Main ingredient part includes: 4-10 parts of American Ginseng, 1-5 parts of Radix Astragali, 2-6 parts of Rhizoma Atractylodis Macrocephalae, 2-8 parts of chicken root, 1-5 parts of aleppo avens herb, rhizoma polygonati 2-5 parts.
3. the drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification according to claim 1, which is characterized in that it is calculated with mass fraction, it is described Dispensing portion includes: 2-6 parts of rubia yunnanensis, 1-6 parts of CAULIS MARSDENIAE TENACISSIMAE, 2-4 parts of radix scutellariae, 0.5-3 parts of Honeysuckle flower, 1-4 parts of Radix Glycyrrhizae.
4. the drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification according to claim 1, which is characterized in that calculated, wrapped with mass fraction It includes: 20-26 parts of main ingredient part, 10-15 parts of dispensing portion.
5. the drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification according to claim 1, which is characterized in that the strengthening vital QI to eliminate pathogenic factors, heat-clearing The drug of poison is ebonite medicine capsule.
6. the drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification according to claim 5, which is characterized in that the system of the ebonite medicine capsule Preparation Method includes:
S1. above-mentioned main ingredient is measured and totally ten one herbal medicine that makes up a prescription with formula, after soaking in water 0.5-3 hours, decoction 1-4 times, often It is 1-3 hours secondary；
S2. merge step S1 and decoct gained medical fluid every time, it is 1.25~1.35 that (45~50 DEG C) to relative density is concentrated after filtering Clear cream；
S3. clear cream obtained by step S2 is mixed with cornstarch, dry, granulation obtains the ebonite medicine capsule after encapsulated.
7. the drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification according to claim 6, which is characterized in that it is soaked in water described in step S1, It is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:5-15.
8. the drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification according to claim 7, which is characterized in that decoct operation described in step S1 At progress 2 times and 2 times or more, soaks in water, calculated with solid-liquid mass ratio, solid phase: liquid phase=1:13-15 before decocting for the first time；Most It is primary afterwards to decoct preceding amount of water, it is calculated with solid-liquid mass ratio, solid phase: liquid phase=1:5-7；Amount of water before the decoction of intermediate number, Solid-liquid mass ratio is successively successively decreased by number is equal.
CN201910625927.7A 2019-07-11 2019-07-11 A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification Pending CN110279803A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910625927.7A CN110279803A (en) 2019-07-11 2019-07-11 A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910625927.7A CN110279803A (en) 2019-07-11 2019-07-11 A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification

Publications (1)

Publication Number Publication Date
CN110279803A true CN110279803A (en) 2019-09-27

Family

ID=68021321

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910625927.7A Pending CN110279803A (en) 2019-07-11 2019-07-11 A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification

Country Status (1)

Country Link
CN (1) CN110279803A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209282A (en) * 2007-12-24 2008-07-02 黄承杰 Preparation method of composite traditional Chinese medicine preparation for treating acquired immuno-deficiency syndrome
CN104352984A (en) * 2014-11-20 2015-02-18 郑心 Lung tumor-inhibiting paste suitable for excessive toxic heat and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209282A (en) * 2007-12-24 2008-07-02 黄承杰 Preparation method of composite traditional Chinese medicine preparation for treating acquired immuno-deficiency syndrome
CN104352984A (en) * 2014-11-20 2015-02-18 郑心 Lung tumor-inhibiting paste suitable for excessive toxic heat and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张栋主编: "《名老中医屡试屡效方》", 31 January 2009, 人民军医出版社 *

Similar Documents

Publication Publication Date Title
CN108030864A (en) A kind of strong medicine liquid for treating traumatic injury, burn and inflammation
CN101559186B (en) Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis
CN111481638A (en) Traditional Chinese medicine enema preparation for treating ulcerative colitis and preparation method thereof
CN110279803A (en) A kind of drug of strengthening vital QI to eliminate pathogenic factors, heat-clearing detoxification
CN102370852A (en) Chinese herbal medicine for treating chronic colitis
CN102670896A (en) Chinese patent medicine for treating bacillary dysentery
CN104306649A (en) Medicament for treating herpes zoster
CN109718262A (en) A kind of Chinese medicine composition for treating allergic rhinitis
CN109349629A (en) A kind of pharynx-clearing throat-benefiting, the Ricipe for health care food for preventing and treating chronic pharyngitis and preparation method thereof
CN109010488A (en) A kind of drug and preparation method thereof for lung heat cough and asthma
KR20190041776A (en) Health tea composition and health tea using medicinal herbs
CN108567867A (en) A kind of Chinese medicine composition that treating chronic nephritis and its application
CN106491954A (en) A kind of treat Chinese medicine composition of lung abscess and preparation method thereof
CN102670897A (en) Chinese herba preparation for treating bacterial dysentery
CN105687365A (en) Traditional Chinese medicine composition for treating polymyositis and preparation method and application of traditional Chinese medicine composition for treating polymyositis
CN105288131A (en) Traditional Chinese medicine decoction for treating renal tuberculosis and preparation method thereof
CN106361874A (en) Yao medicine semiliquidambar cathayensis compound preparation for treating migrating gout and preparation method of semiliquidambar cathayensis compound preparation
CN114404542A (en) Traditional Chinese medicine for treating respiratory infectious diseases
CN104645105B (en) Treat drug and the preparation of the hematuria caused by movement
CN112336844A (en) Traditional Chinese medicine prescription for navel therapy, Du moxibustion and indirect moxibustion
CN104000985A (en) Medicine for treating children dyspepsia and preparation method thereof
CN103933392B (en) A kind of pharmaceutical composition treating xerostomia and application thereof
CN117018138A (en) Traditional Chinese medicine composition for treating chronic renal failure and application thereof
CN103599293B (en) A kind of antitussive and preparation method thereof
CN116492432A (en) Traditional Chinese medicine mixture for treating lung syndrome caused by pathogenic heat of virus infection

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190927